AAAAAA
Results:
1-14
|
Results: 14
Authors:
Bonfanti, P
Landonio, S
Ricci, E
Martinelli, C
Fortuna, P
Faggion, I
Quirino, T
Citation: P. Bonfanti et al., Risk factors for hepatotoxicity in patients treated with highly active antiretroviral therapy, J ACQ IMM D, 27(3), 2001, pp. 316-318
Authors:
Aiuppa, A
Bonfanti, P
Brusca, L
D'Alessandro, W
Federico, C
Parello, F
Citation: A. Aiuppa et al., Evaluation of the environmental impact of volcanic emissions from the chemistry of rainwater: Mount Etna area (Sicily), APPL GEOCH, 16(7-8), 2001, pp. 985-1000
Authors:
Bonfanti, P
Ricci, E
Landonio, S
Valsecchi, L
Timillero, L
Faggion, I
Quirino, T
Citation: P. Bonfanti et al., Predictors of protease inhibitor-associated adverse events, BIOMED PHAR, 55(6), 2001, pp. 321-323
Authors:
Bonfanti, P
Gabbuti, A
Carradori, S
Pusterla, L
Parazzini, F
Landonio, S
Quirino, T
Citation: P. Bonfanti et al., Osteonecrosis in protease inhibitor-treated patients, ORTHOPEDICS, 24(3), 2001, pp. 271-272
Authors:
Bonfanti, P
Valsecchi, L
Parazzini, F
Carradori, S
Pusterla, L
Fortuna, P
Timillero, L
Alessi, F
Ghiselli, G
Gabbuti, A
Di Cintio, E
Martinelli, C
Faggion, I
Landonio, S
Quirino, T
Citation: P. Bonfanti et al., Incidence of adverse reactions in HIV patients treated with protease inhibitors: A cohort study, J ACQ IMM D, 23(3), 2000, pp. 236-245
Authors:
Quirino, T
Niero, F
Ricci, E
Pusterla, L
Carradori, S
Gabbuti, A
Iemoli, E
Landonio, S
Faggion, I
Bonfanti, P
Citation: T. Quirino et al., HAART tolerability: post-exposure prophylaxis in healthcare workers versustreatment in HIV-infected patients, ANTIVIR TH, 5(3), 2000, pp. 195-197
Authors:
Rampazzo, R
D'Onofrio, M
Bonfanti, P
Longhetti, M
Reduzzi, L
Citation: R. Rampazzo et al., Comparative analysis of the properties of bright early-type galaxies in nearby clusters and in the field, ASTROPHYS L, 40(1-2), 2000, pp. 9-31
Authors:
Bonfanti, P
Pusterla, L
Parazzini, F
Libanore, M
Cagni, AE
Franzetti, M
Faggion, I
Landonio, S
Quirino, T
Citation: P. Bonfanti et al., The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX: a randomized multicentric study, BIOMED PHAR, 54(1), 2000, pp. 45-49
Authors:
Bonfanti, P
Faggion, I
Catamancio, SL
Violin, M
Balotta, C
Rusconi, S
Citation: P. Bonfanti et al., Response to antiretroviral therapy in a patient with an uncommon codon 69 insertion in the human immunodeficiency virus type 1 reverse transcriptase, ANTIM AG CH, 44(6), 2000, pp. 1767-1768
Authors:
Quirino, T
Bonfanti, P
Arcidiacono, M
Pusterla, L
Cagni, A
Scaglione, F
Milazzo, F
Citation: T. Quirino et al., Acetylator phenotype prevalence in HIV-infected patients without previous trimethoprim-sulfamethoxazole hypersensitivity, BIOMED PHAR, 53(5-6), 1999, pp. 286-287
Authors:
Bonfanti, P
Capetti, A
Rizzardini, G
Citation: P. Bonfanti et al., HIV disease treatment in the era of HAART, BIOMED PHAR, 53(2), 1999, pp. 93-105
Authors:
Bonfanti, P
Simien, F
Rampazzo, R
Prugniel, P
Citation: P. Bonfanti et al., Kinematics of early-type galaxies in compact groups - HCG 67, HCG 74, and HCG 79, ASTR AST SS, 139(3), 1999, pp. 483-490
Authors:
Camatini, M
Bonfanti, P
Colombo, A
Urani, C
Crippa, S
Citation: M. Camatini et al., Cellular and molecular targets of benzo[a]pyrene and metal toxicity in Xenopus laevis embryos and in Hep G2 cells, ATLA-ALT L, 27(3), 1999, pp. 325-337
Authors:
Rampazzo, R
D'Onofrio, M
Bonfanti, P
Longhetti, M
Reduzzi, L
Citation: R. Rampazzo et al., Star formation history of early-type galaxies in low density environments III. The isophote shape parameter and nuclear line-strength indices, ASTRON ASTR, 341(2), 1999, pp. 357-360
Risultati:
1-14
|